High tumor interstitial fluid pressure identifies cervical cancer patients with improved survival from radiotherapy plus cisplatin versus radiotherapy alone

International Journal of Cancer

Volumn 135, Issue 7, 2014, Pages 1692-1699

  Milosevic, Michael F ^a,b   Pintilie, Melania ^a   Hedley, David W ^a,b   Bristow, Robert G ^a,b   Wouters, Bradly G ^a,b   Oza, Amit M ^a,b   Laframboise, Stephane ^a,c   Hill, Richard P ^a,b   Fyles, Anthony W ^a,b  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

cervical cancer; cisplatin; hypoxia; interstitial fluid pressure (IFP); radiotherapy

Indexed keywords

CISPLATIN;

ARTICLE; BRACHYTHERAPY; CANCER CONTROL; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SIZE; CANCER SURVIVAL; CELL PROLIFERATION; CHEMORADIOTHERAPY; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG EFFICACY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; HYPOXIA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PELVIS LYMPH NODE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE FRACTIONATION; TISSUE PRESSURE; TREATMENT RESPONSE; TUMOR CELL; UTERINE CERVIX CANCER;

CERVICAL CANCER; CISPLATIN; HYPOXIA; INTERSTITIAL FLUID PRESSURE (IFP); RADIOTHERAPY;

ADENOCARCINOMA; ANOXIA; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; CISPLATIN; EXTRACELLULAR FLUID; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PRESSURE; PROGNOSIS; PROSPECTIVE STUDIES; RADIOTHERAPY; SURVIVAL RATE; UTERINE CERVICAL NEOPLASMS;

EID: 84904509373     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28403     Document Type: Article

References (29)

1. Ferlay J, Shin HR, Bray F, et al. Globocan 2008: Cancer Incidence and Mortality Worldwide: International Agency for Research on Cancer, 2010.
2. Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration. Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials. J Clin Oncol 2008; 26: 5802-12.
3. Fyles A, Milosevic M, Pintilie M, et al. Long-term performance of interstial fluid pressure and hypoxia as prognostic factors in cervix cancer. Radiother Oncol 2006; 80: 132-7.
4. Yeo SG, Kim JS, Cho MJ, et al. Interstitial fluid pressure as a prognostic factor in cervical cancer following radiation therapy. Clin Cancer Res 2009; 15: 6201-7.
5. Hockel M, Schlenger K, Aral B, et al. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 1996; 56: 4509-15.
6. Hockel M, Schlenger K, Hockel S, et al. Hypoxic cervical cancers with low apoptotic index are highly aggressive. Cancer Res 1999; 59: 4525-8.
7. Lyng H, Sundfor K, Trope C, et al. Disease control of uterine cervical cancer: relationships to tumor oxygen tension, vascular density, cell density, and frequency of mitosis and apoptosis measured before treatment and during radiotherapy. Clin Cancer Res 2000; 6: 1104-12.
8. Knocke TH, Weitmann HD, Feldmann HJ, et al. Intratumoral p02-measurements as predictive assay in the treatment of carcinoma of the uterine cervix. Radiother Oncol 1999; 53: 99-104.
9. Herrera FG, Chan P, Doll C, et al. A prospective phase I-II trial of the cyclooxygenase-2 inhibitor celecoxib in patients with carcinoma of the cervix with biomarker assessment of the tumor microenvironment. Int J Radiat Oncol Biol Phys 2007; 67: 97-103.
10. Fyles A, Milosevic M, Hedley D, et al. Tumor hypoxia has independent predictor impact only in patients with node-negative cervix cancer. J Clin Oncol 2002; 20: 680-7.
11. Hricak H, Gatsonis C, Chi DS, et al. Role of imaging in pretreatment evaluation of early invasive cervical cancer: results of the intergroup study American College of Radiology Imaging Network 6651-Gynecologic Oncology Group 183. J Clin Oncol 2005; 23: 9329-37.
12. Choi HJ, Kim SH, Seo SS, et al. MRI for pretreatment lymph node staging in uterine cervical cancer. AJR Am J Roentgenol 2006; 187: W538-43.
13. Milosevic M, Fyles A, Hedley D, et al. Interstitial fluid pressure predicts survival in patients with cervix cancer independent of clinical prognostic factors and tumor oxygen measurements. Cancer Res 2001; 61: 6400-5.
14. Hill RP, Marie-Egyptienne DT, Hedley DW,. Cancer stem cells, hypoxia and metastasis. Semin Radiat Oncol 2009; 19: 106-11.
15. Wong RKW, Fyles A, Milosevic M, et al. Heterogeneity of polarographic oxygen tension measurements in cervix cancer: an evaluation of within and between tumor variability, probe position, and track depth. Int J Radiat Oncol Biol Phys 1997;39: 405-12.
16. Doll CM, Milosevic M, Pintilie M, et al. Estimating hypoxic status in human tumors: a simulation using Eppendorf oxygen probe data in cervical cancer patients. Int J Radiat Oncol Biol Phys 2003; 55: 1239-46.
17. Lunt SJ, Fyles A, Hill RP, et al. Interstitial fluid pressure in tumors: therapeutic barrier and biomarker of angiogenesis. Future Oncol 2008; 4: 793-802.
18. Bristow RG, Hill RP,. Hypoxia and metabolism. Hypoxia, DNA repair and genetic instability. Nat Rev Cancer 2008; 8: 180-92.
19. Heldin CH, Rubin K, Pietras K, et al. High interstitial fluid pressure-an obstacle in cancer therapy. Nat Rev Cancer 2004; 4: 806-13.
20. Boucher Y, Jain RK,. Microvascular pressure is the principal driving force for interstitial hypertension in solid tumors: implications for vascular collapse. Cancer Res 1992; 52: 5110-4.
21. Rofstad EK, Ruud EB, Mathiesen B, et al. Associations between radiocurability and interstitial fluid pressure in human tumor xenografts without hypoxic tissue. Clin Cancer Res; 16: 936-45.
22. Padera TP, Stoll BR, Tooredman JB, et al. Pathology: cancer cells compress intratumour vessels. Nature 2004; 427: 695.
23. Fyles A, Keane TJ, Barton M, et al. The effect of treatment duration in the local control of cervix cancer. Radiother Oncol 1992; 25: 273-79.
24. Pearcey R, Brundage M, Drouin P, et al. Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix. J Clin Oncol 2002; 20: 966-72.
25. Nathan SS, DiResta GR, Casas-Ganem JE, et al. Elevated physiologic tumor pressure promotes proliferation and chemosensitivity in human osteosarcoma. Clin Cancer Res 2005; 11: 2389-97.
26. Tsang RW, Fyles AW, Li Y, et al. Tumor proliferation and apoptosis in human uterine cervix carcinoma I: correlations between variables. Radiother Oncol 1999; 50: 85-92.
27. Pintilie M, Iakovlev V, Fyles A, et al. Heterogeneity and power in clinical biomarker studies. J Clin Oncol 2009; 27: 1517-21.
28. Boucher Y, Baxter LT, Jain RK,. Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: implications for therapy. Cancer Res 1990; 50: 4478-84.
29. Hompland T, Ellingsen C, Ovrebo KM, et al. Interstitial fluid pressure and associated lymph node metastasis revealed in tumors by dynamic contrast-enhanced MRI. Cancer Res 2012; 72: 4899-908.